Cyriac Roeding, CEO and co-founder of cancer therapeutics startup Earli, gives his assessment of China's biotech developments, after predicting a decade ago that the country would
become a main competitor to the US. He speaks with Yvonne Man on Bloomberg's The China Show." (Source: Bloomberg)
